Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus [Yahoo! Finance]
Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest [Yahoo! Finance]
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? [Yahoo! Finance]
Collegium to Participate in Upcoming Investor Conferences
Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]